Calamos Wealth Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Calamos Wealth Management’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$553K	Sell
2022 Q4	$535K	Sell
2022 Q3	$484K	Sell
2022 Q2	$614K	Sell
2022 Q1	$717K	Sell
2021 Q4	$826K	Buy
2021 Q1	–	Sell
2020 Q4	$854K	Buy
2020 Q3	$844K	Sell
2020 Q2	$809K	Buy